Skip to content

Evaluating Midazolam effect on post ECT complications in teenagers

Comparative evaluation of midazolam effects before and after seizure occurrence on post ECT complications in teenagers

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160307026950N16
Enrollment
69
Registered
2020-03-11
Start date
2020-02-15
Completion date
Unknown
Last updated
2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

electroconvulsive therapy complications.

Interventions

Intervention 1: Intervention group: group A which receives package A consisted of routine anesthesia medications ( sodium thiopental with a dose of 2 mg/kg and 0.5 mg/kg of succinyl choline) plus 1 mg

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to 18 Years

Inclusion criteria

Inclusion criteria: 13 to 18 years of age ASA I&II Having indications for ECT Written consent from parents NPO regimen

Exclusion criteria

Exclusion criteria: Patients who do not have a stable Hemodynamic status Patients with major diseases like asthma, drug allergy, neuromuscular diseases ,epilepsy, hypertension and cardiovascular diseases

Design outcomes

Primary

MeasureTime frame
Tachycardia - bradycardia. Timepoint: 0 , 5 , 10 , 15 minutes after ECT. Method of measurement: heart monitoring device.;Headache. Timepoint: immediately after full consciousness , every 15 minutes in first hour then every 2 hours until 6 hours. Method of measurement: questionnaire.;Myalgia. Timepoint: immediately after full consciousness , every 15 minutes in first hour then every 2 hours to 6 hour. Method of measurement: questionnaire.;Nausea. Timepoint: immediately after full consciousness , every 15 minutes in first hour then every 2 hours to 6 hour. Method of measurement: questionnaire.;O2 saturation. Timepoint: before injection of drug , during seizure and 5, 10 , 15 minutes after ECT. Method of measurement: pulse oxymetery.;Systolic and diastolic blood pressure. Timepoint: before drug injection, during seizures and after seizures. Method of measurement: Non invasive blood pressure monitor.;Mean blood pressure. Timepoint: before drug injection, during seizures and after seizures. Method of measurement: Non invasive blood pressure monitor.;Recovery time. Timepoint: From the end of seizure to full consciousness. Method of measurement: in minutes using a chornometer.;Specific complications such as hypoxia and respiratory depression. Timepoint: From the end of seizure to full consciousness. Method of measurement: observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Raisi

Esfahan University of Medical Sciences

maryamraisi1995@yahoo.com+98 913 596 7320

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026